Chuang Hao-Yuan 4

What Happened

Chuang Hao-Yuan, Chief Financial Officer of Belite Bio, received 10,000 ordinary shares on April 21, 2026, as the result of restricted stock units (RSUs) vesting after performance criteria were met. The Form 4 reports the transaction as an "other acquisition" (code J) at $0.00 per share, reflecting issuance on vesting rather than an open-market purchase.

Key Details

• Transaction date: 2026-04-21; reported on Form 4 filed 2026-04-23.
• Reported price: $0.00 per share (vesting/award issuance).
• Shares acquired: 10,000 ordinary shares.
• Shares owned after transaction: not specified in the filing.
• Footnote: RSUs were granted on 2025-09-15 and vested on 2026-04-21 when the performance criteria were met.
• Transaction code: J (other acquisition/disposition, used here for RSU vesting).
• Filing timeliness: Reported within the typical 2-business-day window (transaction 04/21, filed 04/23).

Context

This was a compensation-related issuance (performance-based RSU vesting), not a cash purchase or sale. Such vesting events are common for executives and typically result in ordinary income equal to the shares' fair market value at vesting; they do not by themselves indicate buying or selling sentiment.